![Julian Hanak](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Julian Hanak
Plus aucun poste en cours
Profil
Julian Hanak formerly worked at Purespring Therapeutics Ltd., as Chief Executive Officer from 2022 to 2025, NightstaRx Ltd., as Director from 2017 to 2019, and Novasep Holding SAS, as Member-Supervisory Board.
Anciens postes connus de Julian Hanak
| Sociétés | Poste | Fin |
|---|---|---|
Purespring Therapeutics Ltd.
 Purespring Therapeutics Ltd. BiotechnologyHealth Technology Develops therapeutics for the treatment of kidney diseases | Directeur Général | 12/03/2025 |
NightstaRx Ltd.
 NightstaRx Ltd. Medical/Nursing ServicesHealth Services development of therapies for retinal dystrophies | Directeur/Membre du Conseil | 07/06/2019 |
Novasep Holding SAS
 Novasep Holding SAS Chemicals: Major DiversifiedProcess Industries Manufactures fine and agro chemicals & biopharmaceuticals products | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
4
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Novasep Holding SAS
Novasep Holding SAS Chemicals: Major DiversifiedProcess Industries Manufactures fine and agro chemicals & biopharmaceuticals products | Process Industries |
NightstaRx Ltd.
NightstaRx Ltd. Medical/Nursing ServicesHealth Services development of therapies for retinal dystrophies | Health Services |
Purespring Therapeutics Ltd.
Purespring Therapeutics Ltd. BiotechnologyHealth Technology Develops therapeutics for the treatment of kidney diseases | Health Technology |
